Medications affecting the IGF-1/Growth Hormone Axis, including teprotumumab, somatostatin analogues and anti-CGRP monoclonal antibodies, are associated with an elevated reporting odds of alopecia in women; a pharmacovigilance study - SUPPLEMENTAL MATERIAL
收藏NIAID Data Ecosystem2026-05-01 收录
官方服务：
资源简介：
Supplemental data for publication: Medications affecting the IGF-1/Growth Hormone Axis, including teprotumumab, somatostatin analogues and anti-CGRP monoclonal antibodies, are associated with an elevated reporting odds of alopecia in women; a pharmacovigilance study
创建时间：
2023-04-11
